Cargando…
Mitochondria-targeted magnolol inhibits OXPHOS, proliferation, and tumor growth via modulation of energetics and autophagy in melanoma cells
INTRODUCTION: Melanoma is an aggressive form of skin cancer for which there are no effective drugs for prolonged treatment. The existing kinase inhibitor antiglycolytic drugs (B-Raf serine/threonine kinase or BRAF inhibitors) are effective for a short time followed by a rapid onset of drug resistanc...
Autores principales: | Cheng, Gang, Hardy, Micael, Zielonka, Jacek, Weh, Katherine, Zielonka, Monika, Boyle, Kathleen A., Abu Eid, Mahmoud, McAllister, Donna, Bennett, Brian, Kresty, Laura A., Dwinell, Michael B., Kalyanaraman, Balaraman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883397/ https://www.ncbi.nlm.nih.gov/pubmed/32987287 http://dx.doi.org/10.1016/j.ctarc.2020.100210 |
Ejemplares similares
-
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
por: Cheng, Gang, et al.
Publicado: (2019) -
Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death
por: Cheng, Gang, et al.
Publicado: (2013) -
A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds
por: Kalyanaraman, Balaraman, et al.
Publicado: (2017) -
Corrigendum to 'A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [REDOX 14C (2017) 316–327]
por: Kalyanaraman, Balaraman, et al.
Publicado: (2018) -
Mitochondria-targeted hydroxyurea inhibits OXPHOS and induces antiproliferative and immunomodulatory effects
por: Cheng, Gang, et al.
Publicado: (2021)